CrushSCI.com
96.4Average days
88Median days
63Fastest days
149Longest days
662025 publications

Paper Review Records

All Paper Review Records

14 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

86 days

Progress with FAK inhibitors in the patent literature (2020-present)

Authors
Bing-Bing Chen; Rui-Peng Feng; Jin-Bo Niu; Jian Song; Yuan-Bo Cui; Sai-Yang ZhangShow moreShow less
Affiliations
1. Zhengzhou University; 2. The Third Affiliated Hospital of Zhengzhou University; 3. Zhengzhou Central Hospital Affiliated to Zhengzhou UniversityShow moreShow less
Source PDF DOI Publisher page
78 days

Selective PARP1 inhibitors (2021–2025): patent landscape, structural evolution, and future therapeutic opportunities

Authors
Jilong Duan; Yanjing Duan; Dongling Gu; Jia Yang; Fenghua Kang; Youchao Deng; Dongsheng CaoShow moreShow less
Affiliations
1. Central South University; 2. Hong Kong Baptist UniversityShow moreShow less
Source PDF DOI Publisher page
120 days

An updated patent review of STAT6 inhibitors and modulators (2020 – present)

Authors
Muhammad Zafar Irshad Khan; Bo-Qun Du; Mei Xue; Meng-Qian Yu; Shun-Ran Li; Jianshe Wang; Chen-Chen Wang; Xiang-Yang YeShow moreShow less
Affiliations
1. Hangzhou Normal University; 2. Hangzhou Purple Crystal PharmaShow moreShow less
Source PDF DOI Publisher page
79 days

Helicase-primase inhibitors as next-generation anti-HSV agents: from current clinical status to structure–activity relationships and patent coverage

Authors
Christian Gege; Gerald KleymannShow moreShow less
Affiliations
1. Innovative Molecules GmbHShow moreShow less
Source PDF DOI Publisher page
140 days

T-type calcium channel blockers: a review of recent advances (2018–2025)

Authors
Yasinalli Tamboli; Laurent Ferron; Gerald W. ZamponiShow moreShow less
Affiliations
1. King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs (MNGH); 2. University of CalgaryShow moreShow less
Source PDF DOI Publisher page
63 days

Myeloperoxidase (MPO) inhibitors: an updated patent review (2020 - present)

Authors
Zhiwei Meng; Dan Chen; Xingyu Yao; Feng Wang; Zhouling XieShow moreShow less
Affiliations
1. Hefei University of TechnologyShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does EXPERT OPINION ON THERAPEUTIC PATENTS take to review a manuscript?

As of 2026-11-19, CrushSCI has 14 complete review records for EXPERT OPINION ON THERAPEUTIC PATENTS. The fastest paper went from submission to acceptance in 63 days (Myeloperoxidase (MPO) inhibitors: an updated patent review (2020 - present), received 2026-05-21, accepted 2026-07-23); the slowest took 149 days. The average is 96.4 days and the median is 88 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.